Lisa M Rimsza MD
Hematopathology, Anatomic Pathology, Clinical Pathology
Professor, Pathology, University of Arizona College of Medicine
Join to View Full Profile
13400 E Shea BlvdScottsdale, AZ 85259
Phone+1 480-301-8000
Fax+1 480-342-3840
Dr. Rimsza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lisa Rimsza is a pathologist in Scottsdale, AZ and is affiliated with the Mayo Clinic Hospital. She received her medical degree from University of Arizona College of Medicine-Tucson and has been in practice 29 years. She specializes in hematopathology, anatomic pathology, clinical, and molecular pathology.
Education & Training
University of New Mexico School of MedicineFellowship, Hematopathology, 1996 - 1998
University of Arizona College of Medicine-TucsonResidency, Pathology-Anatomic and Clinical, 1992 - 1996- University of Arizona College of MedicineClass of 1992
Certifications & Licensure
AZ State Medical License 1994 - 2025
FL State Medical License 1998 - 2005
NM State Medical License 1996 - 1998
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Hematology
Awards, Honors, & Recognition
- Investigator of the Year Mayo Clinic Arizona, 2020
Clinical Trials
- S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma Start of enrollment: 2009 Apr 01
- SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma Start of enrollment: 1989 Feb 01
- S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone Start of enrollment: 2008 Dec 01
Publications & Presentations
PubMed
- Risk of lymphoid malignancy associated with cancer predisposition genes.Nicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, Cristine Allmer, Allison C Rosenthal
Blood Cancer Journal. 2025-04-19 - Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by Cell-of-Origin.Geffen Kleinstern, Dennis P Robinson, Lisa M Rimsza, Melissa C Larson, Rebecca L King
Cancer Epidemiology, Biomarkers & Prevention. 2025-03-06 - BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma.Katja Gutmair, Diego Villa, Nicholas Cunningham, Elisabeth Silkenstedt, Lisa M Rimsza
Blood Advances. 2025-02-21
Journal Articles
- Validation of the MCL35 Gene Expression Proliferation Assay in Randomized Trials of the European Mantle Cell Lymphoma NetworkLisa Rimsza, MD, British Journal of Haematology
- The MCL35 Gene Expression Proliferation Assay Predicts High‐Risk MCL Patients in a Norwegian Cohort of Younger Patients Given Intensive First Line TherapyLisa Rimsza, MD, British Journal of Haematology
- A Multiprotein Supercomplex Controlling Oncogenic Signalling in LymphomaMaryknoll M Palisoc, Lisa M Rimsza, Stephen M Hewitt, Wyndham H Wilson, Matthias Holdhoff, Fayez Estephan, Nature
- Join now to see all
Abstracts/Posters
- Intraclonal Heterogeneity Caused By Activation-Induced Cytidine Deaminase Is Not a Prognostic Biomarker in Untreated Advanced Stage Follicular Lymphoma: An Analysis of...Lisa M. Rimsza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Over-Expression of Transferrin Receptor (TFRC/CD71) and Low Expression of Innate and Adaptive Immune Cell Subsets in HIV-Associated, GCB-DLBCL By Digital Gene Expressi...Lisa M. Rimsza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 StudyLisa M. Rimsza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Five-Year Outcomes of SWOG S0: A Randomized Phase II US Intergroup Study of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplant for Patients with Ma...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Enhanced DNA Repair and Genomic Stability in HIV(+) Diffuse Large B Cell Lymphoma of Germinal Center Origin2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Surinder K. Puri Memorial Lecture - Lisa Rimsza, MDFebruary 14th, 2020
Science Saturday: Quest to Unmask an Elusive Immune CancerSeptember 8th, 2018
Mayo Clinic Develops Precision Medicine Genomic Diagnostic Test for LymphomaDecember 22nd, 2016
Grant Support
- Molecular Diagnosis And Prognosis In Aggressive LymphomaNational Cancer Institute2011
- Cb: Tissue CoreNational Cancer Institute2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
